Board of Directors

The Alliance Board of Directors is comprised of Principal Investigators (or their designee) from the top 40 accruing Alliance institutions and 10 representatives elected by the Principal Investigators from the remaining main member institutions.

Evanthia Galanis, MD
Group Chair

David Kozono, MD, PhD
Group Vice Chair

PRINCIPAL INVESTIGATORS (OR DESIGNEES)
Tareq Al Baghdadi, MD
Michigan Cancer Research Consortium NCORP
Charalambos Andreadis, MD
UCSF Medical Center-Mount Zion
Nancy Bartlett, MD
Washington University-Siteman Cancer Center LAPS
Lyudmila Bazhenova, MD
UC San Diego Moores Cancer Center
Jeffrey Berenberg, MD
The Hawaii NCORP
Judy Boughey, MD
Mayo Clinic
Harold Burstein, MD, PhD
Dana-Farber/Partners CancerCare LAPS
Kathleen Butler, MD
Cancer Research Consortium of West Michigan NCORP
Jay Carlson, DO
Cancer Research for the Ozarks NCORP
Abigail Caudle, MD
MD Anderson Cancer Center
Ki Chung, MD
NCORP of the Carolinas (Prisma Health NCORP)
Alison Conlin, MD
Pacific Cancer Research Consortium NCORP
Konstantin Dragnev, MD
Dartmouth College-Dartmouth Cancer Center LAPS
Bryan Faller, MD
Heartland Cancer Research NCORP
Darren Feldman, MD
Memorial Sloan Kettering Cancer Center
Bret Friday, MD, PhD
Essentia Health NCI Community Oncology Research Program
Apar Ganti, MD
University of Nebraska Medical Center
Seema Harichand-Herdt, MD
UI Health Care Mission Cancer and Blood-Des Moines Clinic
Sami Ibrahimi, MD, MS
University of Oklahoma Health Sciences Center LAPS
William Irvin, MD
Bon Secours Saint Francis Medical Center
Anthony Jaslowski, MD
Cancer Research of Wisconsin and Northern Michigan Consortium
Yan Ji, MD, PhD
Metro Minnesota Community Oncology Research Consortium
Peter Kaufmann, MD
University of Vermont and State Agricultural College
Chul Kim, MD, MPH
National Capital Area Minority Underserved NCORP
Hedy Kindler, MD
University of Chicago Comprehensive Cancer Center LAPS
Heidi Klepin, MD
Wake Forest University Health Sciences
Jonathan Kolitz, MD
Northwell Health/Center for Advanced Medicine
Matthew Kulke, MD
MaineHealth Cancer Care Network
A. Marilyn Leitch, MD
University of Texas Southwestern Medical Center LAPS
Ellis Levine, MD
Roswell Park Cancer Institute LAPS
Maryam Lustberg, MD, MPH
Yale University-Yale Cancer Center LAPS
Fernando Maciel-Barbosa, MD
University of Iowa/Holden Comprehensive Cancer Center
Gregory Masters, MD
Delaware/Christiana Care NCI Community Oncology Research Program
Matthew Milowsky, MD
UNC Lineberger Comprehensive Cancer Center LAPS
Mahvish Muzaffar, MD
East Carolina University
Ronica Nanda, MD
Morton Plant Hospital
Heather Neuman, MD
University of Wisconsin Carbone Cancer Center
Asit Paul, MD, PhD
VCU Massey Cancer Center Minority Underserved NCORP
John Quigley, MD
University of Illinois
Kendrith Rowland, MD
Carle Cancer Center NCI Community Oncology Research Program
Lewis Silverman, MD
Mount Sinai Hospital
Thomas Stinchcombe, MD
Duke University-Duke Cancer Institute LAPS
J. Marie Suga, MD, MPH
Kaiser Permanente NCI Community Oncology Research Program
Bret Taback, MD
Columbia University NCI Community Oncology Research Program
Scott Tagawa, MD
NYP/Weill Cornell Medical Center
Claire Verschraegen, MD
Ohio State University Comprehensive Cancer Center LAPS
Shamsuddin Virani, MD
Aurora NCI Community Oncology Research Program
Marie Wood, MD
University of Colorado Cancer Center LAPS
Tina Yen, MD
Froedtert and the Medical College of Wisconsin LAPS
Dan Zandberg, MD
UPMC Hillman Cancer Center LAPS

FORMER GROUP CHAIRS
Monica Bertagnolli, MD
Suzanne George, MD
James Ingle, MD
Heidi Nelson, MD
David Ota, MD
Richard Schilsky, MD
Samuel Wells Jr., MD

MODALITY COMMITTEE CHAIRS
Jennifer Dill, CCRP
Missouri Baptist Medical Center
Lisa Kottschade, RN, MSN, CNP
Mayo Clinic
Michael Linden, MD, PhD
University of Minnesota/Masonic Cancer Center
Andrew Nixon, PhD, MBA
Duke University Medical Center
Miguel-Angel Perales, MD
Memorial Sloan Kettering Cancer Center
Chandrajit Raut, MD
Dana-Farber/Harvard Cancer Cente
Joseph Salama, MD
Duke University Medical Center
Lawrence Schwartz, MD
Memorial Sloan Kettering Cancer Center
Elad Sharon, MD, MPH
Dana-Farber/Harvard Cancer Center
Eric Singer, MD
Ohio State University Comprehensive Cancer Center
Daniel Trifiletti, MD
Mayo Clinic in Florida

PROGRAM PRINCIPAL INVESTIGATORS
Isabelle Bedrosian, MD
Procedure-Based Therapy Program
Olwen Hahn, MD
Central Protocol Operations Program
Sumithra Mandrekar, PhD
Statistics and Data Management Program
Electra Paskett, PhD
Cancer Control Program
W. Fraser Symmans, MD
Translational Research Program

ASSOCIATE GROUP CHAIRS
Steven Piantadosi, MD, PhD
Strategic Initiatives and Innovation
Patty Spears
Patient Advocacy
Kimberly Kerstann, PhD
Chief Operating Officer | Liaison - Administrative